Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer
Ace Vision Group announced that it has named Val Kolesnitchenko, MD, as Chief Scientific Officer.
Dr. Kolesnitchenko has served in leadership roles for three decades in clinical ophthalmology practice and industry. Most recently, he held the position of Executive Director of Global Scientific Affairs at Bausch + Lomb, overseeing the medical and clinical development of the company’s surgical portfolio.
Explore More Articles
Laser scleral microporation aids near vision without compromising distance vision
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Robert Ang, MD, discusses results of laser scleral microporation in patients with presbyopia.
read moreLaser scleral microporation has high satisfaction in emmetropic presbyopes
SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Robert Ang, MD, discusses 18-month study outcomes of laser scleral microporation in emmetropic presbyopes. “Our studies show that the patients have high patient satisfaction with laser scleral microporation treatment,” he said. “It is safe and effective, and it has great potential for this segment of …
read moreInfluence of Ocular Rigidity and Ocular Biomechanics on the Pathogenesis of Age-Related Presbyopia
This chapter discusses ocular rigidity and ocular biomechanical dysfunction as they relate to the age-related pathogenesis of presbyopia. The major factors associated with presbyopia as they relate to ocular rigidity and ocular biomechanical dysfunction are highlighted. Furthermore, specific reference is made to modifying the biomechanical properties and structural stiffness of the scleral outer coat utilizing …
read more